Subscribe
News

Pfizer-BioNTech asks FDA to authorize omicron booster for children under 5

By Abigail Adcox
Published
Add Washington Examiner on Google
Pfizer-BioNTech asks FDA to authorize omicron booster for children under 5

Pfizer and BioNTech have asked the Food and Drug Administration for emergency use authorization of their COVID-19 booster targeting omicron subvariants BA.4 and BA.5 and the original strain of the virus from 2020 for children 6 months through 4 years.

Print subscriber? Click here to login/register your account
Digital subscriber? Click here to login/register your account.

Full midterm coverage.Deeper analysis.

Get unlimited access to Washington Examiner's reporting, expert analysis, and coverage of the midterm elections.

Get Unlimited Access

Cancel anytime.

Tag:

Children COVID-19 FDA Vaccines